JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (3): 91-94.doi: 10.6040/j.issn.1673-3770.0.2016.392

Previous Articles     Next Articles

The significance of Maspin and Ets1 in laryngeal squamous carcinoma.

AN Yongming1, MU Wenli2a, TIAN Yanxun3, LI Wei2b, WU Yanqiao4   

  1. 1. Department of Otolaryngology, Jianguo Hospital of Zhangjiakou, Zhangjiakou 075000, Hebei, China;2a. Department of Gastroenterology, 2b. Department of Pathology, The 251st Hospital of Chinese PLA, Zhangjiakou 075000, Hebei, China;3. Department of Otolaryngology, Peoples Hospital of Xingtai, Xingtai 054000, Hebei, China;4. Department of Otolaryngology, Bethune International Peace Hospital, Shijiazhuang 050000, Hebei, China
  • Received:2016-09-07 Online:2017-06-16 Published:2017-06-16

PDF (PC)

364

Abstract: Objective To investigate the significance of Maspin, an anti-oncogene, and the transcription factor Ets1 in laryngeal squamous carcinoma. Methods The expression of Maspin and Ets1 was evaluated in 70 samples of laryngeal squamous carcinoma and 30 samples of non-cancerous adjacent tissues by immunohistochemistry(EnVisionTM, Fuzhou Mai Xin Biological Ltd. Co., China). Results The difference in the positive rates of expression of Maspin and Ets1 between the laryngeal squamous carcinoma and adjacent samples was statistically significant(P<0.05)Positive expression of Maspin was associated with tumor size, histological classification, TNM staging, and Ki-67 expression(P<0.05). Additionally, positive expression of Ets1 was associated with histological classification, TNM staging, lymph node metastasis, and Ki-67 expression(P<0.05). However, there was negative correlation between the expression of Maspin and Ets1 in laryngeal squamous carcinoma. Conclusion Maspin and Ets1 are involved in the progression of laryngeal squamous carcinoma; their expression not only reflects the malignant degree of laryngeal squamous carcinoma, but also is helpful in further expounding related mechanisms in the development of laryngeal squamous carcinoma.

Key words: Ets1, Immunohistochemistry, Maspin, Laryngeal squamous carcinoma

CLC Number: 

  • R739.65
[1] 黄选兆,汪吉宝. 实用耳鼻咽喉科学[M]. 北京: 人民卫生出版社, 2005: 502-506.
[2] 高鹏,王培戈,范晓琳, 等. Maspin和E-cadherin蛋白表达与胃癌临床病理学的关系[J].山东医药,2007,47(6):30-31.
[3] 齐淑轶, 蔡勇, 邓莅霏, 等. Maspin在非小细胞肺癌组织中的表达及意义[J]. 山东医药,2012, 52(3):9-11. QI Shuyi, CAI Yong, DENG Lifei, et al. Maspin expression and its clinical significance in non-small cell lung cancer[J]. Shandong Med J, 2012, 52(3):9-11.
[4] 杨伟萍, 韦长元, 周建华, 等. Maspin在65例乳腺癌中的表达及其临床意义[J]. 肿瘤学杂志,2010, 16(3):163-167. YANG Weiping, WEI Changyuan, ZHOU Jianhua, et al. Expression of Maspin in 65 Cases with Breast Cancer and its Significance[J]. J Oncol, 2010, 16(3):163-167.
[5] 杨娜, 安牧尔. Maspin和VEGF-C蛋白表达与卵巢癌发生及临床病理学的关系[J].疑难病杂志, 2012, 11(4):274-276. YANG Na, AN Muer. Expression of Maspin and VEGF-C protein in human ovarian carcinoma and its relationship with clinicopathological variables[J]. Chin J Diff Complicated Cases, 2012, 11(4):274-276.
[6] 邸丽双,王德华,高阳. Maspin和Caspase-3在宫颈癌中的表达及相关性[J]. 天津医科大学学报,2009, 15(1):77-80. DI Lishuang, WANG Dehua, GAO Yang. The expression and correlation of Maspin and Caspase-3 in cervical carcinoma[J]. J Tianjin Med Univ, 2009, 15(1):77-80.
[7] 吴齐斌, 宋一一, 孙蓬明. Maspin基因在妇科恶性肿瘤中的研究进展[J]. 海峡预防医学杂志,2012, 18(1):25-27.
[8] Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility an adhesion in aggressive breast cancer cells[J]. Cancer Biol Ther, 2003, 2(4):398-403.
[9] Shi HY, Zhang W, Liang R, et al. Modelinghuman breast cancer metastasis in mice:maspin as a paradigm[J]. Histol Histopathol, 2003, 18(1):201-206.
[10] 马瑛. Maspin在肿瘤中的研究进展[J].中国现代药物应用,2015, 9(22):250-251.
[11] Song SH, Park HM, Eom DW, et al. The expression of p16(INK4a)and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins[J]. Int J Gynecol Cancer, 2007, 17(4):858-867.
[12] Oikawa T. ETS transcription factors: possible targets for cancer therapy[J]. Cancer Sci, 2004, 95(8):626-633.
[13] 于湧,张一楚. Ets家族转录因子及其与肿瘤浸润转移的关系[J]. 国外医学肿瘤学分册, 2003, 30(3):177-179. YU Yong, ZHANG Yichu. Ets family of transcription factors and its relationship with tumor infiltration and metastasis[J]. Foreign Med Sci(Cancer Section), 2003, 30(3):177-179.
[14] 王新允,孙翠云,郑海燕,等. 肺癌中Etsl mRNA和c-Met蛋白表达细胞芯片的研究[J]. 国际呼吸杂志,2008, 28(1):1-3.
[15] 任涛文,周永宁,吴静. 等. 胃癌组织中Ets-1的表达及其与血管生成临床病理特征和预后的关系[J]. 中华肿瘤杂志,2009, 31(9):674-677. REN Taowen, ZHOU Yongning, WU Jing, et al. Relationship between Ets-1 expression and angiogenesis,clinicopathological features and survival of patients with gastric carcinoma[J]. Chin J Oncol, 2009, 31(9):674-677.
[16] 何常, 陈佳, 钟愉,等. 结直肠癌内Ets-1、血管内生长因子C蛋白及微血管和微淋巴管密度的意义[J].中华病理学杂志, 2007, 36(5):331-332.
[17] 郑丽娟, 卢启明. Ets-1和E-cadherin 在食管鳞状细胞癌中的表达及临床意义[J].中华消化内镜杂志,2010,27(4):204-205.
[18] Pap Z, Pavai Z, Denes L, et al. An immunohistochemical study of colon adenomas and carcinomas:E-cadherin, Syndecan-1, Ets-1[J]. Pathol Oncol Res, 2009, 15(4):579-587.
[19] Zhang M, Volpert O, Shi YH, et al. Maspin is anangiogenesis inhibitor[J]. Nat Med, 2000, 6(2):196-199.
[20] 周立莉,葛新国,蔡茂怀,等. 非小细胞肺癌中ETS-1与E-cadherin、N-cadherin、Vimentin表达相关性的研究[J].癌症进展,2015, 13(5):504-511. ZHOU Lili, GE Xinguo, CAI Maohuai, et al. The correlation between expression of ETS-1 and E-cadherin, N-cadherin and Vimentin in non-small cell lung cancer[J]. Oncol Prog, 2015, 13(5):504-511.
[1] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[2] LI Gui, YANG Yanli, LI Donghai, YAN Xiuying. Adult orbital xanthogranulomatous disease with clinicopathological analysis report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 80-85.
[3] LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce. Rosai-Dorfman disease of the bilateral neck and nasopharynx: a case report and review of related cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 108-114.
[4] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[5] YANG Kaiyan, TANG Fengzhu, QIN Qicai, LI Xuxiang, FENG Dayi, NONG Fengjing, YANG Qiuyun. Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 18-25.
[6] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[7] CHENG Yao, ZHANG Zhen, YANG Ji, FENG Chengmin, DENG Qicheng, ZHANG Xi, ZHAO Rui, ZHU Xin, WU Junzhi, LIU Hai, DENG Shishan. Expression and clinical significance of CIP2A in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 40-44.
[8] XUE Gang, SUN Xinmin, LIN Xu, WU Jingfang. Expression and clinical significance of the KCNK5 double-pore potassium channel protein in papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 64-69.
[9] . Expression of cyclin E2 in hypopharyngeal cancer and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 132-137.
[10] JIANG Ningning, WANG Penglai, YUAN Changyong, HUANG Xiaofeng, JIANG Changwei, LIU Zongxiang,SUN Tiezhong. The expression and significance of metastasis suppressor 1 protein in tongue squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 64-67.
[11] XU Li, WANG Zhiyi, CHEN Wei, XUE Fei, ZHANG Yong, CHENG You, JI Junfeng, CUI Pengcheng, JIANG Manjie. Effect of MicroRNA-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 30-37.
[12] LI Hao, LI Yanzhong, WANG Yan. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression in the soft palate of [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 43-47.
[13] ZHANG Menglu, LI Yongtuan.. Expression of chemokine ligand 27 in secondary middle ear cholesteatoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 46-48.
[14] LI Fu, ZHAO Shuyou. Expression of tumor suppressor in lung cancer 1 in laryngeal squamous cell carcinoma and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 36-38.
[15] WEI Xi-jian1, YIN Rui-lan2, GUO Xing3. Expression of a proliferation-inducing ligand in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 14-16.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd